AI Article Synopsis

  • Coronaviruses, including SARS-CoV-2 which causes COVID-19, are common in humans and animals; previous studies indicated genetic variants in the ACE2 gene might affect susceptibility to SARS-CoV-2 infection.
  • The study analyzed genetic variants of the ACE2 gene in 131 Italian COVID-19 patients and a control group of 1,000 individuals using whole-exome sequencing.
  • Findings revealed three ACE2 variants, with one variant showing a potentially significant difference in frequency against other populations, but overall there was no strong evidence linking ACE2 variants to COVID-19 severity in the cohort.

Article Abstract

Background: Coronaviruses (CoV) are a large family of viruses that are common in humans and many animal species. Animal coronaviruses rarely infect humans with the exceptions of the Middle East respiratory syndrome ( MERS-CoV ), the severe acute respiratory syndrome corona virus (SARS-CoV), and now SARS-CoV-2, which is the cause of the ongoing pandemic of coronavirus disease 2019 (COVID-19). Several studies suggested that genetic variants in the ACE2 gene may influence the host susceptibility or resistance to SARS-CoV-2 infection according to the functional role of ACE2 in human pathophysiology. However, many of these studies have been conducted in silico based on epidemiological and population data. We therefore investigated the occurrence of ACE2 variants in a cohort of 131 Italian unrelated individuals clinically diagnosed with COVID-19 and in an Italian control population, to evaluate a possible allelic association with COVID-19, by direct DNA analysis.

Methods: As a pilot study, we analyzed, by whole-exome sequencing, genetic variants of ACE2 gene in 131 DNA samples of COVID-19 patients hospitalized at Tor Vergata University Hospital and at Bambino Gesù Children's Hospital, Rome. We used a large control group consisting of 1000 individuals (500 males and 500 females).

Results: We identified three different germline variants: one intronic c.439+4G>A and two missense c.1888G>C p.(Asp630His) and c.2158A>G p.(Asn720Asp) in a total of 131 patients with a similar frequency in male and female. Thus far, only the c.1888G>C p.(Asp630His) variant shows a statistically different frequency compared to the ethnically matched populations. Therefore, further studies are needed in larger cohorts, since it was found only in one heterozygous COVID-19 patient.

Conclusions: Our results suggest that there is no strong evidence, in our cohort, of consistent association of ACE2 variants with COVID-19 severity. We might speculate that rare susceptibility/resistant alleles could be located in the non-coding regions of the ACE2 gene, known to play a role in regulation of the gene activity.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7483483PMC
http://dx.doi.org/10.1186/s40246-020-00279-zDOI Listing

Publication Analysis

Top Keywords

genetic variants
12
ace2 gene
12
131 italian
8
respiratory syndrome
8
variants ace2
8
ace2 variants
8
c1888g>c pasp630his
8
variants
6
covid-19
6
ace2
6

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!